← Back to Search

Loop Diuretic

Furosemide for High Blood Pressure

Phase 1 & 2
Recruiting
Led By Annet Kirabo
Research Sponsored by Vanderbilt University Medical Center
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
New or pre-existing diagnosis of essential hypertension defined as systolic blood pressure >140 mmHg or >90 mmHg diastolic or taking antihypertensive medications regardless of current blood pressure
Be between 18 and 65 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up over 3 days
Awards & highlights

Study Summary

This trial will test whether or not salt-sensitive hypertension can be diagnosed by monocyte salt-sensitivity.

Who is the study for?
This trial is for adults aged 18-60 with a healthy BMI (18.5-24.9) who have high blood pressure, either newly diagnosed or existing, and are currently on medication or have blood pressure above certain levels. It's not open to those with diabetes, recent vaccinations, pregnancy, substance abuse issues, metal implants, autoimmune diseases, claustrophobia that prevents MRI scans or those who've had a recent heart event.Check my eligibility
What is being tested?
The study tests if the drug Furosemide at 40 mg can be used as an indicator of salt-sensitivity in people with high blood pressure by observing immune cell activation. The goal is to see if this response correlates with hypertension due to salt intake.See study design
What are the potential side effects?
Furosemide may cause dehydration and electrolyte imbalances leading to symptoms like dry mouth/thirsty feeling, confusion or weakness; it might also lead to increased urination.

Eligibility Criteria

Inclusion Criteria

You may be eligible if you check “Yes” for the criteria below
Select...
I have high blood pressure or am on medication for it.

Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~over 3 days
This trial's timeline: 3 weeks for screening, Varies for treatment, and over 3 days for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.
Primary outcome measures
The percent of participants with salt sensitive blood pressure
Secondary outcome measures
Percent of participants with immune cell activation

Trial Design

1Treatment groups
Experimental Treatment
Group I: Weinberger protocolExperimental Treatment1 Intervention
During the Weinberger protocol, salt loading will be achieved by the combination of a high-salt diet (isocaloric, 160 mEq Na and 70 mEq K), and an infusion of 2L of saline (300 mEq Na+). Patients will have free access to water but their food will be limited to that provided by the protocol. Salt depletion will be accomplished by administering an isocaloric diet containing 10 mEq Na and 70 mEq K and continued unlimited water intake. At 8 am, 12 noon and 4 pm, subjects will be given 40 mg of furosemide or lasix orally.
Treatment
First Studied
Drug Approval Stage
How many patients have taken this drug
Furosemide
FDA approved

Find a Location

Who is running the clinical trial?

Vanderbilt University Medical CenterLead Sponsor
861 Previous Clinical Trials
673,163 Total Patients Enrolled
Annet KiraboPrincipal Investigator - Vanderbilt University Medical Center
Vanderbilt University Medical Center

Media Library

Furosemide 40 mg (Loop Diuretic) Clinical Trial Eligibility Overview. Trial Name: NCT03753204 — Phase 1 & 2
High Blood Pressure Research Study Groups: Weinberger protocol
High Blood Pressure Clinical Trial 2023: Furosemide 40 mg Highlights & Side Effects. Trial Name: NCT03753204 — Phase 1 & 2
Furosemide 40 mg (Loop Diuretic) 2023 Treatment Timeline for Medical Study. Trial Name: NCT03753204 — Phase 1 & 2

Frequently Asked Questions

These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.

Does this experiment have an age limit?

"The specific age requirements to enroll in this particular trial are between 18 and 60 years old. However, there are 84 other studies for patients that fall outside of this range (under 18 or over 65)."

Answered by AI

How many people have signed up to take part in this research project?

"Yes, the trial is currently recruiting patients. According to information on clinicaltrials.gov, the study was posted on September 1st 2021 and last updated on October 27th 2021. The research needs 20 participants at a single site."

Answered by AI

Are there other scientific papers that mention the use of Furosemide 40 mg?

"There are currently 16 active clinical trials studying the effects of Furosemide 40 mg. Out of these, 6 are in Phase 3. Most notably, 44 different locations across America are running these trials."

Answered by AI

What are some conditions that Furosemide 40 mg is known to ameliorate?

"Furosemide 40 mg is an effective diuretic for treating heart failure, edema, and acute pulmonary edema."

Answered by AI

Are people still able to sign up for this clinical trial?

"The research team is currently looking for participants, as indicated by the clinicaltrials.gov website. This particular trial was originally posted on September 1st, 2021 and has since been updated on October 27th, 2021."

Answered by AI

Who is eligible to participate in this research?

"20 patients, who must be within the age bracket of 18 and 60 and currently have inflammation, will be enrolled in this study. In addition, the following criteria must be met: We will perform a pilot analysis in 20 hypertensive subjects controlled for gender (50% men, 50% women), age (18-60 years), New or pre-existing diagnosis of essential hypertension defined as systolic blood pressure >140 mmHg or >90 mmHg diastolic or taking antihypertensive medications regardless of current blood pressure., BMI (18.5-24.9). Only subjects who give informed consent will be studied"

Answered by AI
~6 spots leftby Sep 2025